| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +19% |
| 3Y CAGR | +9% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +49% |
| 3Y CAGR | +10% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
PfizerPFIZER | ₹4,999.50 +79.50 (1.62%) | 22,514.29 | 30.62 | 5.36 | ||
Caplin Point LaboratoriesCAPLIPOINT | ₹2,548.40 +18.70 (0.74%) | 19,234.00 | 28.37 | 5.36 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹7,433.50 -73.50 (0.98%) | 18,760.75 | 110.6 | 21.5 | ||
Natco PharmaNATCOPHARM | ₹882.70 +5.20 (0.59%) | 15,721.37 | 13.73 | 1.7 |